Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for healthcare industry professionals · Thursday, May 1, 2025 · 808,471,908 Articles · 3+ Million Readers

Sleep Number Announces First Quarter 2025 Results

April 30, 2025 --

Sleep Number Corporation (Nasdaq: SNBR) today reported results for the quarter ended March 29, 2025.

Linda Findley, President and CEO, commented, “We are laser focused on delivering strong returns for shareholders and are taking a different approach to the Sleep Number business. I see a way to run our business on a lower cost basis without compromising our topline. We are fundamentally changing how we operate. We implemented an organizational redesign, including changes to our leadership team, to simplify decision making and bring us closer to the customer. With that change, we reduced corporate management roles by 21%. In addition, we are reshaping key functions within the company, including marketing and research and development, to further drive efficiency. Since I joined three weeks ago, our efforts have reduced second quarter operating expenses by approximately 10% of our current cost structure, as of the first quarter of 2025."

“Sleep Number is truly differentiated and no one else does what we do. With the organizational changes implemented, we are now focused on building a strategy for growth with our customers at the center. I joined Sleep Number because I believe strongly in the company’s long-term potential, and I am confident that we can change our trajectory to drive sustainable growth and profitability.”

Financial Highlights (all comparisons year-over-year unless otherwise noted)

  • Net sales of $393 million were down 16%, driven by lower volume and a reduced store count.
  • Gross profit was $241 million, a decrease of $36 million. Gross profit margin increased 250 basis points to 61.2%, driven by the company’s ongoing efforts to reduce material input cost and efficiency gains in its home delivery and logistics operations, along with a more favorable product mix.
  • Operating expenses were $237 million before restructuring and other non-recurring costs, a decrease of $23 million, or 9%, primarily driven by lower marketing and selling expenses.
  • Net loss was $8.6 million, or $0.38 per diluted share, down $1.2 million, driven primarily by lower net sales, partially offset by higher gross profit margin and lower operating expenses.
  • Adjusted EBITDA was $22 million, down 41%, driven by a decline in net sales and associated loss of fixed cost leverage, partially offset by an improved gross margin rate and lower operating expenses. Adjusted EBITDA margin declined 230 basis points to 5.6%.

Cash Flows, Liquidity and Balance Sheet Highlights (all comparisons year-over-year unless otherwise noted)

  • Net cash used in operating activities was $2.6 million for the quarter, down $36 million.
  • Free cash flow was a use of $7.2 million for the quarter, down $32 million.
  • The company’s leverage ratio was 4.46x EBITDAR on a trailing 12-month basis at the end of the quarter versus the covenant maximum of 4.75x.

Company’s Organizational Changes

In a separate press release today, the company announced a series of changes to its Executive Leadership Team reporting to Findley as part of an organizational redesign. The redesign also included broader changes across senior level roles. By consolidating overlapping capabilities and eliminating overspecialized roles, the company is now a more streamlined organization that the company believes will drive efficiency, increase accountability and accelerate decision-making to strengthen performance within a range of economic environments. With this change, Sleep Number reduced corporate management roles by 21%. With new leadership in place, the company anticipates further streamlining under each new function over the coming weeks.

The company has also taken aggressive, strategic actions to reduce expenses without compromising its topline, including marketing and research and development investments, through a sharper focus on near- and intermediate-term customer value. These actions are anticipated to reduce the company’s cost structure by $80 to $100 million before restructuring costs on an annualized basis as compared to the first quarter of 2025. Approximately 35% of these costs are fixed, including research and development and general and administrative costs; 50% are structural changes to the marketing model for more efficiency; and 15% are volume-driven.

Financial Outlook

Given the recent leadership transition, changes being implemented within the business, and the rapidly evolving macroeconomic environment, the company will not be providing a 2025 outlook at this time. The company will continue to reassess its ability to provide such guidance as the new leadership team evaluates the company’s strategy and the macroeconomic and consumer demand environment.

Conference Call Information

Management will host its regularly scheduled conference call to discuss the company’s results at 5 p.m. EDT (4 p.m. CDT; 2 p.m. PDT) today. To access the webcast, please visit the investor relations area of the Sleep Number website at https://ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days.

About Sleep Number Corporation

Sleep Number is a sleep wellness company. We are guided by our purpose to improve the health and wellbeing of society through higher quality sleep; to date, our innovations have improved nearly 16 million lives. Our sleep wellness platform helps solve sleep problems, whether it’s providing individualized temperature control for each sleeper through our Climate360® smart bed or applying our 33 billion hours of longitudinal sleep data and expertise to research with global institutions.

Our smart bed ecosystem drives best-in-class engagement through dynamic, adjustable, and effortless sleep with personalized sleep and health insights; our millions of Smart Sleepers are loyal brand advocates. And our 3,600 mission-driven team members passionately innovate to drive value creation through our vertically integrated business model, including our exclusive direct-to-consumer selling in nearly 640 stores and online.

To learn more about life-changing, individualized sleep, visit a Sleep Number® store near you, our newsroom and investor relations sites, or SleepNumber.com.

Forward-looking Statements

Statements used in this news release relating to future plans, events, financial results or performance, such as the statements that: the new organizational structure and accelerated cost saving initiatives introduced in the second quarter of 2025 have expected annualized operating expense reductions of $80 to $100 million before restructuring costs from the cost structure as compared to the first quarter of 2025 with approximately 35% of these costs being fixed, 50% being structural changes and 15% being volume-driven; the company has plans to run the business on a lower cost basis without compromising the topline; the company is fundamentally changing how it operates; the organizational redesign will simplify decision making, bring the company closer to the consumer, drive efficiency, increase accountability and accelerate decision-making to strengthen performance within a range of economic environments; the company can change its trajectory to drive sustainable growth and profitability; the company anticipates further streamlining under each new organizational function over the coming weeks; and future plans to issue financial guidance are forward-looking statements subject to certain risks and uncertainties which could cause the company’s results to differ materially. The most important risks and uncertainties are described in the company’s filings with the Securities and Exchange Commission, including in Item 1A of the company’s Annual Report on Form 10-K and other periodic reports. Forward-looking statements speak only as of the date they are made, and the company does not undertake any obligation to update any forward-looking statement.

 
SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Consolidated Statements of Operations

(unaudited – in thousands, except per share amounts)

 

 

Three Months Ended

 

March 29,
2025

 

% of

Net Sales

 

March 30,
2024

 

% of

Net Sales

Net sales

$

393,261

 

 

100.0

%

 

$

470,449

 

 

100.0

%

Cost of sales

 

152,726

 

 

38.8

%

 

 

194,275

 

 

41.3

%

Gross profit

 

240,535

 

 

61.2

%

 

 

276,174

 

 

58.7

%

Operating expenses:

 

 

 

 

 

 

 

Sales and marketing

 

189,103

 

 

48.1

%

 

 

208,512

 

 

44.3

%

General and administrative

 

38,619

 

 

9.8

%

 

 

39,079

 

 

8.3

%

Research and development

 

10,903

 

 

2.8

%

 

 

12,441

 

 

2.6

%

Restructuring costs

 

60

 

 

%

 

 

10,600

 

 

2.3

%

Total operating expenses

 

238,685

 

 

60.7

%

 

 

270,632

 

 

57.5

%

Operating income

 

1,850

 

 

0.5

%

 

 

5,542

 

 

1.2

%

Interest expense, net

 

11,081

 

 

2.8

%

 

 

12,299

 

 

2.6

%

Loss before income taxes

 

(9,231

)

 

(2.3

%)

 

 

(6,757

)

 

(1.4

%)

Income tax (benefit) expense

 

(585

)

 

(0.1

%)

 

 

725

 

 

0.2

%

Net loss

$

(8,646

)

 

(2.2

%)

 

$

(7,482

)

 

(1.6

%)

 

 

 

 

 

 

 

 

Net loss per share – basic

$

(0.38

)

 

 

 

$

(0.33

)

 

 

 

 

 

 

 

 

 

 

Net loss per share – diluted

$

(0.38

)

 

 

 

$

(0.33

)

 

 

 

 

 

 

 

 

 

 

Reconciliation of weighted-average shares outstanding:

Basic weighted-average shares outstanding

 

22,706

 

 

 

 

 

22,506

 

 

 

Dilutive effect of stock-based awards

 

 

 

 

 

 

 

 

 

Diluted weighted-average shares outstanding

 

22,706

 

 

 

 

 

22,506

 

 

 

 

For the three months ended March 29, 2025 and March 30, 2024, potentially dilutive stock-based awards have been excluded from the calculation of diluted weighted-average shares outstanding, as their inclusion would have had an anti-dilutive effect on our net loss per diluted share.

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Consolidated Balance Sheets

(unaudited – in thousands, except per share amounts)

subject to reclassification

 

 

March 29,
2025

 

December 28,
2024

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

1,691

 

 

$

1,950

 

Accounts receivable, net of allowances of $1,112 and $1,113, respectively

 

14,225

 

 

 

17,516

 

Inventories

 

103,876

 

 

 

103,152

 

Prepaid expenses

 

17,570

 

 

 

14,568

 

Other current assets

 

38,004

 

 

 

44,098

 

Total current assets

 

175,366

 

 

 

181,284

 

Non-current assets:

 

 

 

Property and equipment, net

 

119,780

 

 

 

129,574

 

Operating lease right-of-use assets

 

345,483

 

 

 

356,641

 

Goodwill and intangible assets, net

 

66,357

 

 

 

66,412

 

Deferred income taxes

 

34,896

 

 

 

33,575

 

Other non-current assets

 

94,909

 

 

 

93,324

 

Total assets

$

836,791

 

 

$

860,810

 

Liabilities and Shareholders’ Deficit

 

 

 

Current liabilities:

 

 

 

Borrowings under revolving credit facility

$

557,700

 

 

$

546,600

 

Accounts payable

 

114,312

 

 

 

107,619

 

Customer prepayments

 

40,357

 

 

 

46,933

 

Accrued sales returns

 

16,777

 

 

 

19,092

 

Compensation and benefits

 

21,371

 

 

 

31,038

 

Taxes and withholding

 

17,430

 

 

 

18,619

 

Operating lease liabilities

 

82,614

 

 

 

82,307

 

Other current liabilities

 

53,818

 

 

 

55,804

 

Total current liabilities

 

904,379

 

 

 

908,012

 

Non-current liabilities:

 

 

 

Operating lease liabilities

 

294,295

 

 

 

307,201

 

Other non-current liabilities

 

94,961

 

 

 

97,183

 

Total non-current liabilities

 

389,256

 

 

 

404,384

 

Total liabilities

 

1,293,635

 

 

 

1,312,396

 

Shareholders’ deficit:

 

 

 

Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding

 

 

 

 

 

Common stock, $0.01 par value; 142,500 shares authorized, 22,660 and 22,388 shares issued and outstanding, respectively

 

227

 

 

 

224

 

Additional paid-in capital

 

30,775

 

 

 

27,390

 

Accumulated deficit

 

(487,846

)

 

 

(479,200

)

Total shareholders’ deficit

 

(456,844

)

 

 

(451,586

)

Total liabilities and shareholders’ deficit

$

836,791

 

 

$

860,810

 

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(unaudited – in thousands)

subject to reclassification

 

 

Three Months Ended

 

March 29,
2025

 

March 30,
2024

Cash flows from operating activities:

 

 

 

Net loss

$

(8,646

)

 

$

(7,482

)

Adjustments to reconcile net loss to net cash (used in) provided by

operating activities:

 

 

 

Depreciation and amortization

 

14,836

 

 

 

17,487

 

Stock-based compensation

 

3,951

 

 

 

4,117

 

Net loss on disposals and impairments of assets

 

17

 

 

 

2,500

 

Deferred income taxes

 

(1,321

)

 

 

(928

)

Changes in operating assets and liabilities:

 

 

 

Accounts receivable

 

3,291

 

 

 

5,026

 

Inventories

 

(724

)

 

 

14,529

 

Income taxes

 

736

 

 

 

1,587

 

Prepaid expenses and other assets

 

781

 

 

 

5,473

 

Accounts payable

 

8,784

 

 

 

(2,765

)

Customer prepayments

 

(6,576

)

 

 

1,119

 

Accrued compensation and benefits

 

(9,686

)

 

 

30

 

Other taxes and withholding

 

(1,925

)

 

 

(2,060

)

Other accruals and liabilities

 

(6,144

)

 

 

(4,888

)

Net cash (used in) provided by operating activities

 

(2,626

)

 

 

33,745

 

 

 

 

 

Cash flows from investing activities:

 

 

 

Purchases of property and equipment

 

(4,599

)

 

 

(9,308

)

Issuance of notes receivable

 

 

 

 

(2,942

)

Net cash used in investing activities

 

(4,599

)

 

 

(12,250

)

 

 

 

 

Cash flows from financing activities:

 

 

 

Net increase (decrease) in short-term borrowings

 

9,087

 

 

 

(21,396

)

Repurchases of common stock

 

(563

)

 

 

(570

)

Debt issuance costs

 

(1,558

)

 

 

 

Net cash provided by (used in) financing activities

 

6,966

 

 

 

(21,966

)

 

 

 

 

Net decrease in cash and cash equivalents

 

(259

)

 

 

(471

)

Cash and cash equivalents, at beginning of period

 

1,950

 

 

 

2,539

 

Cash and cash equivalents, at end of period

$

1,691

 

 

$

2,068

 

SLEEP NUMBER CORPORATION

AND SUBSIDIARIES

Supplemental Financial Information

(unaudited)

 

 

Three Months Ended

 

March 29,
2025

 

March 30,
2024

Percent of sales:

 

 

 

Retail stores

 

87.6

%

 

 

88.2

%

Online, phone, chat and other

 

12.4

%

 

 

11.8

%

Total Company

 

100.0

%

 

 

100.0

%

 

 

 

 

Sales change rates:

 

 

 

Retail comparable-store sales

 

(15

%)

 

 

(10

%)

Online, phone and chat

 

(12

%)

 

 

(19

%)

Total Retail comparable sales change

 

(15

%)

 

 

(11

%)

Net opened/closed stores and other

 

(1

%)

 

 

0

%

Total Company

 

(16

%)

 

 

(11

%)

 

 

 

 

Stores open:

 

 

 

Beginning of period

 

640

 

 

 

672

 

Opened

 

2

 

 

 

6

 

Closed

 

(5

)

 

 

(17

)

End of period

 

637

 

 

 

661

 

 

 

 

 

Other metrics:

 

 

 

Average sales per store ($ in 000's) 1

$

2,495

 

 

$

2,786

 

Average sales per square foot 1

$

807

 

 

$

903

 

Stores > $2 million net sales 2

 

51

%

 

 

63

%

Stores > $3 million net sales 2

 

15

%

 

 

23

%

Average revenue per smart bed unit 3

$

5,992

 

 

$

5,765

 

1

Trailing twelve months Total Retail comparable sales per store open at least one year.

2

Trailing twelve months for stores open at least one year (excludes online, phone and chat sales).

3

Represents Total Retail (stores, online, phone and chat) net sales divided by Total Retail smart bed units.

SLEEP NUMBER CORPORATION AND SUBSIDIARIES
Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)
(in thousands)

We define earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net loss plus: income tax (benefit) expense, interest expense, depreciation and amortization, stock-based compensation, restructuring costs, CEO transition/proxy contest costs, and asset impairments. Management believes Adjusted EBITDA is a useful indicator of our financial performance and our ability to generate cash from operating activities. Our definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure:

 

Three Months Ended

 

Trailing Twelve Months Ended

 

March 29,
2025

 

March 30,
2024

 

March 29,
2025

 

March 30,
2024

Net loss

$

(8,646

)

 

$

(7,482

)

 

$

(21,498

)

 

$

(34,234

)

Income tax (benefit) expense

 

(585

)

 

 

725

 

 

 

(6,472

)

 

 

(9,107

)

Interest expense

 

11,081

 

 

 

12,299

 

 

 

47,150

 

 

 

45,892

 

Depreciation and amortization

 

14,406

 

 

 

17,145

 

 

 

62,240

 

 

 

71,633

 

Stock-based compensation

 

3,951

 

 

 

4,117

 

 

 

11,278

 

 

 

14,333

 

Restructuring costs 1

 

60

 

 

 

10,600

 

 

 

7,526

 

 

 

26,328

 

CEO transition/Proxy contest costs 2

 

1,774

 

 

 

 

 

 

2,772

 

 

 

 

Asset impairments

 

 

 

 

 

 

 

1,220

 

 

 

660

 

Adjusted EBITDA

$

22,041

 

 

$

37,404

 

 

$

104,216

 

 

$

115,505

 

1

Represents costs related to business restructuring actions initiated in the fourth quarter of fiscal 2023.

2

Represents costs related to CEO transition activities and proxy contest costs of $0.6 million and $1.2 million, respectively, for the three months ended March 29, 2025 and $0.8 million and $2.0 million, respectively, for the trailing twelve months ended March 29, 2025. These costs were both initiated in the fourth quarter of fiscal 2024.

Free Cash Flow

(in thousands)

 

 

Three Months Ended

 

Trailing Twelve Months Ended

 

March 29,
2025

 

March 30,
2024

 

March 29,
2025

 

March 30,
2024

Net cash (used in) provided by operating activities

$

(2,626

)

 

$

33,745

 

$

(9,228

)

 

$

6,136

 

Subtract: Purchases of property and equipment

 

4,599

 

 

 

9,308

 

 

18,796

 

 

 

50,808

 

Free cash flow

$

(7,225

)

 

$

24,437

 

$

(28,024

)

 

$

(44,672

)

Note - Our Adjusted EBITDA calculations and Free Cash Flow data are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.

GAAP - generally accepted accounting principles in the U.S.

SLEEP NUMBER CORPORATION AND SUBSIDIARIES

Calculation of Net Leverage Ratio under Revolving Credit Facility

(in thousands)

 

 

Trailing Twelve Months Ended

 

March 29,
2025

 

March 30,
2024

Borrowings under revolving credit facility

$

557,700

 

$

523,500

Outstanding letters of credit

 

6,847

 

 

7,147

Finance lease obligations

 

221

 

 

300

Consolidated funded indebtedness

$

564,768

 

$

530,947

Operating lease liabilities 1

 

376,909

 

 

424,746

Total debt including operating lease liabilities (a)

$

941,677

 

$

955,693

 

 

 

 

Adjusted EBITDA (see above)

$

104,216

 

$

115,505

Consolidated rent expense

 

106,967

 

 

112,233

Consolidated EBITDAR (b)

$

211,183

 

$

227,738

Net Leverage Ratio under revolving credit facility (a divided by b)

4.5 to 1.0

 

4.2 to 1.0

1 Reflects operating lease liabilities included in our financial statements under ASC 842.
 

Note - Our Net Leverage Ratio under Revolving Credit Facility, Adjusted EBITDA and EBITDAR calculations are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.

GAAP - generally accepted accounting principles in the U.S.

SLEEP NUMBER CORPORATION AND SUBSIDIARIES
Calculation of Return on Invested Capital (Adjusted ROIC)
(in thousands)

Adjusted ROIC is a financial measure we use to determine how efficiently we deploy our capital. It quantifies the return we earn on our adjusted invested capital. Management believes Adjusted ROIC is also a useful metric for investors and financial analysts. We compute Adjusted ROIC as outlined below. Our definition and calculation of Adjusted ROIC may not be comparable to similarly titled definitions and calculations used by other companies. The tables below reconcile adjusted net operating profit after taxes (Adjusted NOPAT) and total adjusted invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures:

 

Trailing Twelve Months Ended

 

March 29,
2025

 

March 30,
2024

Adjusted net operating profit after taxes (Adjusted NOPAT)

 

 

 

Operating income

$

19,180

 

 

$

2,550

 

Add: Operating lease interest 1

 

26,098

 

 

 

27,882

 

Less: Income taxes 2

 

(10,022

)

 

 

(7,479

)

Adjusted NOPAT

$

35,256

 

 

$

22,953

 

 

 

 

 

Average adjusted invested capital

 

 

 

Total deficit

$

(456,844

)

 

$

(445,863

)

Add: Long-term debt 3

 

557,921

 

 

 

523,800

 

Add: Operating lease liabilities 4

 

376,909

 

 

 

424,746

 

Total adjusted invested capital at end of period

$

477,986

 

 

$

502,683

 

 

 

 

 

Average adjusted invested capital 5

$

487,361

 

 

$

505,498

 

 

 

 

 

Adjusted ROIC 6

 

7.2

%

 

 

4.5

%

1

Represents the interest expense component of lease expense included in our financial statements under ASC 842, Leases.

2

Reflects annual effective income tax rates, before discrete adjustments, of 22.1% and 24.6% for March 29, 2025 and March 30, 2024, respectively.

3

Long-term debt includes existing finance lease liabilities.

4

Reflects operating lease liabilities included in our financial statements under ASC 842.

5

Average adjusted invested capital represents the average of the last five fiscal quarters' ending adjusted invested capital balances.

6

Adjusted ROIC equals Adjusted NOPAT divided by average adjusted invested capital.

 

 

Note - The Company's Adjusted ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable to, GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.

GAAP - generally accepted accounting principles in the U.S.

 

Powered by EIN Presswire

Distribution channels:

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release